Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026Abivax Presents First Evidence of Anti-Fibrotic Activity for Obefazimod Alongside New Clinical Efficacy and Safety Analyses in Inflammatory Bowel Disease at ECCO 2026
Texas Precious Metals Partners with Breakaway Roping Star Josie ConnerSHINER, Texas , Feb. 20, 2026 (GLOBE NEWSWIRE) -- Texas Precious Metals is pleased to announce a partnership with breakaway roping star, Josie Conner. Standing at the forefront of women’s rodeo, Conner was named WPRA Resistol Rookie of the Year in 2022, is a four-time Wrangler NFBR qualifier, and owns the 2024 and 2025 AQHA Horse of the Year.
VERSES Announces Filing of Quarterly Report on Form 10-Q for the Three and Nine-Months Ended December 31, 2025VANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- VERSES AI Inc. (CBOE: VERS) (OTCQB: VRSSF) ("VERSES" or the "Company"), a cognitive computing company pioneering next-generation agentic software systems today announced that it has filed its Quarterly Report on Form 10-Q (“Quarterly Report”) for the three months and nine months ended December 31, 2025, with the U.S. Securities and Exchange Commission (“SEC”).
Berger Montague PC Investigating Claims on Behalf of Investors in NuScale Power Corporation (NYSE: SMR) After Class Action FilingPHILADELPHIA, Feb. 20, 2026 (GLOBE NEWSWIRE) -- National plaintiffs’ law firm Berger Montague PC announces that a class action lawsuit has been filed against NuScale Power Corporation (
NYSE: SMR) (“NuScale” or the “Company”) on behalf of investors who purchased or otherwise acquired NuScale securities during the period from May 13, 2025 through November 6, 2025 (the “Class Period”).
KD SHAREHOLDER ALERT: Securities Fraud Lawsuit Filed on Behalf of Kyndryl Holdings, Inc. Investors - Contact Kirby McInerney LLP by April 13, 2026NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (
NYSE:KD) securities to contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests in the securities fraud class action lawsuit at no cost.
K2 Capital Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Rights, Commencing on February 25, 2026NEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- K2 Capital Acquisition Corp. (the "Company") today announced that, commencing on February 25, 2026, holders of the 13,800,000 units (the “Units”) sold in the Company’s initial public offering (the “Offering”), including Units sold upon full exercise of the underwriters’ over-allotment option, may elect to separately trade the Class A ordinary shares and rights included in the Units. Any Units not separated will continue to trade on the NASDAQ Global Market (“NASDAQ”) under the symbol “KTWOU.” Any underlying Class A ordinary shares and rights that are separated will trade on the NASDAQ under the symbols “KTWO” and “KTWOR,” respectively. Holders of Units will need to have their brokers contact the Company's transfer agent, VStock Transfer, in order to separate the holders’ Units into Class A ordinary shares and rights.
Razny Jewelers Acquires 109 East Oak Street, Significantly Expanding its Presence in Chicago’s Prestigious Luxury CorridorOwnership of Two Oak Street Properties Solidifies Razny Jewelers’ Three Generations of Investment in Chicago and an Enduring Standard of Craftmanship, Service and Trust
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)SAN CARLOS, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (
NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on February 19, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 3,600 shares of Iovance’s common stock to two new, non-executive employees.
Equinox Gold Announces Filing of 2025 Audited Financial StatementsVANCOUVER, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Equinox Gold Corp. (TSX: EQX, NYSE American: EQX) (the “Company”) has filed its audited financial statements and related management’s discussion and analysis for the three months and year ended December 31, 2025. The documents are available for download on the Company’s profile on SEDAR+ at www.sedarplus.ca, on EDGAR at www.sec.gov/edgar and on the Company’s website at www.equinoxgold.com.
PYPL Stockholder Alert: Shareholder Rights Law Firm Robbins LLP Reminds Investors of the Class Action Lawsuit Against PayPal Holdings, Inc.SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired PayPal Holdings, Inc. (
NASDAQ: PYPL) securities between February 25, 2025 and February 2, 2026. PayPal is an international company that enables digital payments to simplify commerce experiences.
AirBoss to Release 4th Quarter and FY 2025 Earnings on March 4, 2026NEWMARKET, Ontario, Feb. 20, 2026 (GLOBE NEWSWIRE) -- AirBoss of America Corp. (TSX: BOS) (OTCQX:ABSSF) (the “Company” or “AirBoss”) today announced that it will release its fourth quarter and unaudited full year 2025 results after markets close on March 4, 2026. The release will be followed by a conference call to discuss the results on Thursday, March 5, 2026, at 9:00 am ET. The Company will file its audited annual consolidated financial statements and related management’s discussion and analysis for the year ended December 31, 2025 following the conclusion of the audit and in accordance with applicable securities laws.
Navient declares first quarter common stock dividendHERNDON, Va., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Navient (Nasdaq: NAVI) announced that its board of directors approved a 2026 first quarter dividend of $0.16 per share on the company's common stock.
Bragar Eagel & Squire, P.C. Reminds Bath & Body Works and BellRing Brands Investors With Large Losses to Contact the Firm Regarding Filed Class ActionsNEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Bath & Body Works, Inc. (
NYSE:BBWI) and BellRing Brands, Inc. (
NYSE:BRBR). Stockholders have until the deadlines below to petition the court to serve as lead plaintiff. Additional information about each case can be found at the link provided.
OST Class Action Alert: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Securities Fraud Class Action Against Ostin Technology Group Co., Ltd.SAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Ostin Technology Group Co., Ltd. (
NASDAQ: OST) ordinary shares between May 11, 2025 and June 26, 2025. OST purports to be a manufacturer of thin-film transistor liquid crystal display ("TFT-LCD") modules and polarizers used in consumer electronics, commercial LCD displays, and automotive displays.
ENPH Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Enphase Energy, Inc. Class Action LawsuitSAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Enphase Energy, Inc. (
NASDAQ: ENPH) securities between April 22, 2025 and October 28, 2025. Enphase is a global energy technology company focusing on solutions for solar generation, storage, and communication.
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NOVATO, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (
NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 22,917 restricted stock units of the company’s common stock to six newly hired non-executive officers of the company. The awards were approved by the compensation committee of the company’s board of directors and granted under the Ultragenyx Employment Inducement Plan, with a grant date of February 16, 2026, as an inducement material to the new employees entering into employment with Ultragenyx in accordance with Nasdaq Listing Rule 5635(c)(4).
Abony Acquisition Corp. I Announces Closing of $230 Million Initial Public Offering Including Exercise of Underwriter’s Over-Allotment Option in FullAUSTIN, TX, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Abony Acquisition Corp. I (Nasdaq: AACOU) (the “Company”) today announced the closing of its initial public offering of 23,000,000 units, which includes 3,000,000 units issued pursuant to the exercise by the underwriter of its over-allotment option in full, at a public offering price of $10.00 per unit. Each unit sold in the offering consists of one Class A ordinary share and one-third of one redeemable warrant, with each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments.
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)WALTHAM, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative therapies for patients living with autoimmune diseases, today announced that on February 17, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options to purchase an aggregate of 35,700 shares of the Company’s common stock (“Stock Options”) and an aggregate of 53,625 restricted stock units of the Company’s common stock (“RSUs”) to newly hired employees of the Company as an inducement material to such employees’ entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)MALVERN, Pa., Feb. 20, 2026 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (
NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 8,550 shares of its common stock to three newly-hired employees, with a grant date of February 18, 2026 (the "Grant Date"). The restricted stock units were granted pursuant to the Nasdaq Rule 5635(c)(4) inducement grant exception as a component of each individual's employment compensation and were granted as an inducement material to his or her acceptance of employment with TELA Bio.
MARTEN TRANSPORT DECLARES QUARTERLY DIVIDENDMONDOVI, Wis., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Marten Transport, Ltd. (Nasdaq/GS:MRTN) announced today that its Board of Directors has declared a regular quarterly cash dividend of $0.06 per share of common stock. The dividend will be payable on March 31, 2026 to stockholders of record at the close of business on March 17, 2026.
U.S. Global Investors Reports 12% Sequential Growth in Assets Under Management in Q2 of Fiscal 2026SAN ANTONIO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- U.S. Global Investors, Inc. (
NASDAQ: GROW) (the “Company”), a registered investment advisory firm1 with longstanding experience in global markets and specialized sectors, today reported financial results for the second quarter of fiscal 2026 ended December 31, 2025. Total assets under management (AUM) were approximately $1.5 billion at quarter-end, representing a 12% increase from the prior quarter and 5% higher than AUM at the end of the year-ago quarter. This rose to $1.7 billion in total AUM as of Thursday, February 19. Operating revenue increased by $259,000, or 11.5%, compared to the prior quarter, and by $279,000 compared to the quarter ended December 31, 2024. Additionally, the Company’s expenses decreased by $172,000 in the current quarter compared to the same quarter last year. The Company’s income before taxes was $535,000, a significant improvement from a loss before taxes of $116,000 in the quarter ended December 31, 2024.
Averin Capital Acquisition Corp. Completes $250,000,000 Initial Public OfferingNew York, NY, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Averin Capital Acquisition Corp. (the “Company”) announced today the closing of its initial public offering of 25,000,000 units. The offering was priced at $10.00 per unit, resulting in gross proceeds of $250,000,000.
Colliers Extends Maturity and Enhances Flexibility of its US$2.25 Billion Credit FacilityTORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Colliers (NASDAQ and TSX: CIGI), a global leader in professional services and investment management, announced today that it has amended its revolving credit facility. The amended agreement extends the maturity to February 2031, providing significant long-term financial flexibility.
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)CAMBRIDGE, Mass., Feb. 20, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4” or “the Company”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that on February 16, 2026 (the “Grant Date”), the Compensation Committee of the Company’s Board of Directors granted a non-qualified stock option to purchase 8,000 shares of the Company’s common stock to a newly hired employee of the Company as an inducement material to such employee’s entry into employment with the Company, in accordance with Nasdaq Listing Rule 5635(c)(4) (the “Inducement Grant”).
OTTAWA BANCORP, INC. EXTENDS STANDSTILL AGREEMENT WITH STILWELL GROUPOTTAWA, Ill., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Ottawa Bancorp, Inc. (the “Company”) (OTCQX: OTTW), the holding company for OSB Community Bank (the “Bank”), announced today that the Company has entered into an extension of its standstill agreement (the “Agreement”) with Stilwell Activist Fund, L.P., Stilwell Activist Investments, L.P., Stilwell Partners, L.P., Stilwell Value LLC, and Joseph Stilwell (collectively, the “Stilwell Group”). As a result of the extension, the Agreement will now remain in effect through the close of business on the date of the Company’s 2027 Annual Meeting of Stockholders, unless the Agreement is terminated earlier in accordance with its terms.
CoreWeave, Inc. Notice of March 13, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application DeadlineNEW YORK and NEW ORLEANS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., notifies investors in CoreWeave, Inc. (“CoreWeave” or the “Company”) (NasdaqGS: CRWV) of a class action securities lawsuit.
Surge Copper Announces Berg Project Acceptance into BC Critical Minerals OfficeVancouver, British Columbia, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Surge Copper Corp. (TSXV: SURG) (OTCQB: SRGXF) (Frankfurt: G6D2) (“Surge” or the “Company”) is pleased to announce the British Columbia government’s acceptance of the Berg Project into the Critical Minerals Office (“CMO”).
Inscope Raises $14.5M Series A to Replace Manual Financial Statement Preparation for Accounting Firms and EnterprisesSAN FRANCISCO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Inscope, the AI-powered financial reporting platform built for accounting firms and enterprises, today announced it has raised $14.5 million in Series A funding. The round was led by Norwest, with participation from Storm Ventures, existing investors Better Tomorrow Ventures and Lightspeed Venture Partners, and strategic operators across finance and enterprise software.
ENPH Investors Have Opportunity to Lead Enphase Energy, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Enphase Energy, Inc. (“Enphase” or “the Company”) (
NASDAQ: ENPH) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RGNX Investors Have Opportunity to Lead REGENXBIO Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against REGENXBIO Inc. (“Regenxbio” or “the Company”) (
NASDAQ: RGNX) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
KD Investors Have Opportunity to Lead Kyndryl Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Kyndryl Holdings, Inc. (“Kyndryl” or “the Company”) (
NYSE: KD) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
QURE Investors Have Opportunity to Lead uniQure N.V. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against uniQure N.V. (“uniQure” or “the Company”) (
NASDAQ: QURE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PYPL Investors Have Opportunity to Lead PayPal Holdings, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against PayPal Holdings, Inc. (“PayPal” or “the Company”) (
NASDAQ: PYPL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PSFE Investors Have Opportunity to Lead Paysafe Limited Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Paysafe Limited (“Paysafe” or “the Company”) (
NYSE: PSFE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended-Release Injectable Suspension (TEV-'749) for the Once-Monthly Treatment of Schizophrenia in AdultsPARSIPPANY, N.J. and TEL AVIV, Israel and PARIS, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), and Medincell (Euronext: MEDCL), announced today that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for olanzapine extended-release injectable suspension (TEV-'749) for the treatment of schizophrenia in adults. TEV-'749 is designed to improve real-world treatment adherence and help patients maintain long-term stability, with the goal of addressing a critical treatment gap for people living with schizophrenia.
INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Inovio Pharmaceuticals, Inc. (“Inovio” or “the Company”) (
NASDAQ: INO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Cleanroom Film & Bags Adds High-speed Converting Line to Serve Increasing Demand for Cleanroom BagsPLACENTIA, Calif., Feb. 20, 2026 (GLOBE NEWSWIRE) -- Cleanroom Film and Bags (CFB) has expanded operations with a new high-speed cleanroom bag production line to support increasing demand from medical, life sciences and advanced manufacturing customers. CFB’s new bags-on-rolls converting line incorporates advanced automation, precision sealing and consistent roll winding to produce cleanroom bags with clean tears, strong seals and dependable performance in critical applications including:
Optica Names 22 Recipients for 2026 Awards and MedalsWASHINGTON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Optica, Advancing Optics and Photonics Worldwide, is pleased to announce the recipients of several of its 2026 awards and medals. These awards highlight outstanding technical, research, educational, business, leadership and service accomplishments.
In NCLA Win, Supreme Court Agrees Trump Admin. Cannot Use IEEPA to Impose Emergency TariffsLearning Resources, Inc. and hand2mind, Inc. v. President Donald J. Trump, et al.; President Donald J. Trump, et al. v. V.O.S. Selections, Inc., et al.
Federal Home Loan Bank of New York Announces Full-Year and Fourth Quarter 2025 Operating HighlightsNEW YORK, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Federal Home Loan Bank of New York (“FHLBNY”) today released its unaudited financial highlights for the quarter and year ended December 31, 2025.
DAISO OPENS NEW STORE LOCATION IN NORMAL, ILLINOISNormal, Illinois, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Daiso, the globally recognized retail chain known for offering affordable and unique products, is excited to announce the opening of its latest store in Normal, Illinois on January 24th, 2026. Located at College Plaza, this store marks a significant milestone in Daiso’s U.S. expansion.
DAISO OPENS NEW STORE LOCATION IN KENDALL, FLORIDA FEATURING EXCLUSIVE STANDARD PRODUCTS LINEMiami, Florida, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Daiso, the globally recognized retail chain known for offering affordable and unique products, is excited to announce the opening of its latest store in Kendall, Florida on February 14th, 2026. Located at Higate Square, this store marks a significant milestone in Daiso’s U.S. expansion. This is also the first Florida Daiso location to feature Daiso's new brand, Standard Products.
LyondellBasell to address 2026 Bank of America Global Agriculture and Materials ConferenceHOUSTON and LONDON, Feb. 20, 2026 (GLOBE NEWSWIRE) -- LyondellBasell (
NYSE: LYB), a leader in the global chemical industry, today announced that Agustin Izquierdo, executive vice president and chief financial officer, will participate in a fireside chat at the 2026 Bank of America Global Agriculture and Materials Conference in Fort Lauderdale, Fla., on Thursday, February 26, 2026, at 9:45 a.m. EST.
DAISO OPENS NEW STORE LOCATION IN MADERA, CALIFORNIAMadera, California, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Daiso, the globally recognized retail chain known for offering affordable and unique products, is excited to announce the opening of its latest store in Madera, California on January 24th, 2026. Located at Madera Marketplace, this store marks a significant milestone in Daiso’s U.S. expansion.
DOOR Investors Have Opportunity to Lead Masonite International Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Masonite International Corporation (“Masonite” or “the Company”) (
NYSE: DOOR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
ORCL Investors Have Opportunity to Lead Oracle Corporation Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Oracle Corporation (“Oracle” or “the Company”) (
NYSE: ORCL) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RARE Investors Have Opportunity to Lead Ultragenyx Pharmaceutical Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or “the Company”) (
NASDAQ: RARE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Mereo BioPharma Group plc (“Mereo” or “the Company”) (
NASDAQ: MREO) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PMI Investors Have Opportunity to Lead Picard Medical, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Picard Medical, Inc. (“Picard” or “the Company”) (NYSE American: PMI) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
PLUG Investors Have Opportunity to Lead Plug Power Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Plug Power Inc. (“Plug Power” or “the Company”) (
NASDAQ: PLUG) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
RR Investors Have Opportunity to Lead Richtech Robotics Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Richtech Robotics Inc. (“Richtech” or “the Company”) (
NASDAQ: RR) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
METC Investors Have Opportunity to Lead Ramaco Resources, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Ramaco Resources, Inc. (“Ramaco” or “the Company”) (
NASDAQ: METC) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
BYND Investors Have Opportunity to Lead Beyond Meat, Inc. Securities Fraud Lawsuit with the Schall Law FirmLOS ANGELES, Feb. 20, 2026 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Beyond Meat, Inc. (“Beyond Meat” or “the Company”) (
NASDAQ: BYND) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Transaction in Own SharesTransaction in Own Shares
United States Mint Director Paul Hollis to Participate in American Numismatic Association National Money ShowWASHINGTON, D.C., Feb. 20, 2026 (GLOBE NEWSWIRE) -- United States Mint (Mint) Director Paul Hollis will participate in the 2026 American Numismatic Association (ANA) National Money Show from February 26 to 28 at the Savannah Convention Center, 1 International Drive in Savannah, Georgia. Director Hollis will participate in the ribbon-cutting ceremony—his first time doing so as the 41st Mint director.
IPG Launches “Packaging Diagnostics” to Optimize Global Packaging Line PerformanceThe new unified service platform integrates advanced monitoring, adhesion testing, and expert audits to maximize uptime and operational efficiency
ESET’s Ryan Grant Named a 2026 CRN Channel ChiefSAN DIEGO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- ESET, a global leader in cybersecurity, today announced that CRN®—a brand of The Channel Company—has selected Ryan Grant, Country Manager, U.S. and Canada, for inclusion on the prestigious 2026 CRN® Channel Chiefs list. This annual recognition celebrates IT vendor and distribution executives who are shaping channel strategy and driving innovation and partnership across the industry. 2026 marks the fourth consecutive year Grant has been named a CRN Channel Chief.
Hudbay Receives New Ingerbelle Expansion Permits for Copper MountainTORONTO, Feb. 20, 2026 (GLOBE NEWSWIRE) -- Hudbay Minerals Inc. (“Hudbay” or the “Company”) (TSX, NYSE: HBM) is pleased to announce that it has received key permit amendments for the New Ingerbelle expansion project at its Copper Mountain mine located in British Columbia, Canada. The Company received the amended Mines Act and Environmental Management Act permits through the coordinated authorizations process managed by the British Columbia Major Mines Office (“MMO”). This milestone enhances the copper and gold production profile at Copper Mountain, secures a longer mine life, protects more than 800 jobs and ensures continued economic benefits at the local, regional and federal levels.
Sanford Heisler Sharp McKnight Files $134 Million ERISA Class Action Case Against Stifel Financial, Corp. on Behalf of More Than 10,000 Retirement Plan ParticipantsSuit alleges Stifel breached fiduciary duties by retaining underperforming funds for over a decade costing its employees and retirees significant retirement savings
